Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care

NCT: NCT07738874 · NOT_YET_RECRUITING

NCT IDNCT07738874
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2031-12-31
SponsorDuke University (OTHER)
First posted
Last updated

Brief Summary

Retinopathy of prematurity (ROP) is a disorder of development of the retina and its vasculature that can impact vision in vulnerable preterm neonates for a lifetime. A major barrier to improving ROP outcomes is the lack of easy access and low stress means to obtain objective measures of ROP disease severity across the retina in these infants. The long-term goal of this program is to provide information which will improve preterm infant health and vision via objective bedside imaging and analysis that characterizes retina-wide ROP level of disease, its response to treatment and development, and to rapidly translate this for better early intervention and improved future vision care.

Frequently Asked Questions

What is Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care?

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care is a clinical trial registered under NCT07738874. Current status: NOT_YET_RECRUITING.

What is the status of NCT07738874?

The current status of NCT07738874 (Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care) is: NOT_YET_RECRUITING.

When did Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care start?

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.